Action 000597 NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Northeast Pharmaceutical Group Co., Ltd.

Actions

000597

CNE0000009G0

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 30/04/2024 		Varia. 5j. Varia. 1 janv.
4,75 CNY +1,93% Graphique intraday de Northeast Pharmaceutical Group Co., Ltd. +1,50% -11,21%
25/04 Northeast Pharmaceutical Group Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI
29/03 Northeast Pharmaceutical Group Co. publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Northeast Pharmaceutical Group Co., Ltd. Proposes Profit Distribution for 2023
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Northeast Pharmaceutical's Levocarnitine Gets Nod to Enter EU Market
Northeast Pharmaceutical's Piracetam Passes Generic Drug Evaluation in China
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Northeast Pharmaceutical to Set Up Joint Venture With Muscat Changming Investments in Oman
Northeast Pharmaceutical Group Co., Ltd.(XSEC:000597) added to S&P Global BMI Index
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Northeast Pharmaceutical Group Co., Ltd. Announces 2022 Final Cash Profit Distribution Plan, Payable on 16 May 2023
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Northeast Pharmaceutical Group Co., Ltd. Approves Final Cash Dividend for 2022
Northeast Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for 2022
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
China Monthly Antitrust Update - March 2023
Northeast Pharma Appoints Former Bank Auditor as CFO
Northeast Pharmaceutical Unit Registers Anti-Seizure Drug in China
Northeast Pharmaceutical’s Piracetam Tablets Gets Regulatory Approval
Northeast Pharmaceutical Gets Supplementary Drug Application Approval For Tinidazole Tablets
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 000597
  4. Actualités Northeast Pharmaceutical Group Co., Ltd.
  5. Autres langues